ADVANTAN

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Estonia, Finland, Germany, Hong Kong SAR China, Lithuania, Malta, Mexico, New Zealand, Poland, Romania, South Africa, Turkey, UK.

Active ingredients

The drug ADVANTAN contains one active pharmaceutical ingredient (API):

1	Methylprednisolone UNII ET54W9J4U2 - METHYLPREDNISOLONE ACEPONATE
	Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system.
	Read more about Methylprednisolone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ADVANTAN Cream, Ointment	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC14	Methylprednisolone aceponate	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10830B, 10833E, 10834F, 10835G, 10836H, 10838K, 10839L, 10840M, 10842P, 10843Q, 10844R, 10845T, 10846W, 10848Y, 10851D, 10852E, 10853F, 10855H, 10856J, 8054X, 8055Y, 8128T, 8618N
BR	Câmara de Regulação do Mercado de Medicamentos	538912050012613, 538912050012713, 538912050016413, 541121020002517, 541121020002617, 541121020002717
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00259407, 00259413, 03113905, 03113911, 03113928, 03113934, 04939240, 04939257, 04939263, 04939292, 04939300, 04939317, 04939352, 04939369, 07376949
EE	Ravimiamet	1028102, 1062009, 1133356, 1133367
FI	Lääkealan turvallisuus- ja kehittämiskeskus	381079
GB	Medicines & Healthcare Products Regulatory Agency	195224
HK	Department of Health Drug Office	43662, 44065
HR	Agencija za lijekove i medicinske proizvode	HR-H-429835039, HR-H-434685681
LT	Valstybinė vaistų kontrolės tarnyba	1000038, 1003228, 1004341, 1054536, 1075376, 1081252, 1085797, 1085837, 1089372, 1091519, 1091881
MT	Medicines Authority	MA024/01501, PI1438/10401A, PI908/11901A, PI908/11902A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	444M97
NZ	Medicines and Medical Devices Safety Authority	6260, 6261
PL	Rejestru Produktów Leczniczych	100074900, 100074923, 100074930, 100255429, 100345606, 100406236, 100406420, 100410491, 100413294, 100417719, 100418802, 100419457, 100419724, 100419919, 100451704, 100462748, 100462920, 100467025
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66593001, W66593002, W66594001, W66594002, W66594003, W66594004, W66594005, W66595001, W66595002, W66595003, W66595004, W66595005
TR	İlaç ve Tıbbi Cihaz Kurumu	8699514350255, 8699514350262, 8699514350316, 8699514380092, 8699514380108, 8699514380115, 8699514380122, 8699514480037
ZA	Health Products Regulatory Authority	32/13.4.1/0361, 32/13.4.1/0362, X/13.4.1/384, X/13.4.1/385, X/13.4.1/386